Boston Scientific Corporation
BSX Healthcare Medical Devices
Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 7.53%, EPS grew 14.8%, free cash flow grew 13.3% and total debt rose 8.95%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow BSX
Boston Scientific Corporation (BSX) EBITDA
Boston Scientific Corporation's EBITDA for fiscal 2025 was $5.0B, up 18.0% from $4.3B in fiscal 2024. Over the twelve months to 30 June 2026 it was $5.6B. Over the past ten years it has ranged from $505.0M (fiscal 2015) to $5.0B (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 5 consecutive fiscal years. Boston Scientific Corporation ranks 4th of 147 Medical Devices companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $5.0B | 17.98% |
| FY2024 | $4.3B | 18.43% |
| FY2023 | $3.6B | 23.40% |
| FY2022 | $2.9B | 9.55% |
| FY2021 | $2.7B | 68.74% |
| FY2020 | $1.6B | (40.11%) |
| FY2019 | $2.6B | 8.13% |
| FY2018 | $2.4B | 14.16% |
| FY2017 | $2.1B | 67.56% |
| FY2016 | $1.3B | 152.08% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $1.5B | 5.72% |
| Mar 2026 | $1.5B | 21.95% |
| Dec 2025 | $1.2B | (14.40%) |
| Sep 2025 | $1.4B | 15.65% |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| ABT Abbott Laboratories compare | $10.8B |
| MDT Medtronic PLC compare | $9.7B |
| SYK Stryker Corporation compare | $6.8B |
| BSX Boston Scientific Corporation | $5.6B |
| PHG Koninklijke Philips N.V. compare | $3.4B |
| GEHC GE HealthCare Technologies Inc. compare | $3.3B |
| STE STERIS plc compare | $1.6B |
| EW Edwards Lifesciences Corporation compare | $1.6B |
| DXCM DexCom, Inc. compare | $1.4B |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on BSX
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement